Substances for countries

Active ingredient Administration route ATC Level 1 ATC Level 2 Year of switch wdt_ID Country Status Indication Pharmaceutical form Strength Dosage/posology Population Additional information (advertising restriction) wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at
Acetylcysteine Oral R R05 23088 Austria OTC Secretolytic therapy for acute and chronic bronchopulmonary diseases associated with a disruption in mucus formation and transport. Acetylcysteine 100mg - soluble tablets are used in adults and Children aged two and over and teenagers. 100mg, 200mg, 600mg For oral use. admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 23089 Belgium OTC Chronic bronchitis, cystic fibrosis, acute respiratory tract disorders 200mg, 600mg, 2%, 4% Adults and children over 2 years of age. admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 23090 Bulgaria OTC Secretolytic treatment of acute and chronic bronchopulmonary diseases accompanied by impaired secretion formation and transmission in adults and adolescents over 2 and 14 years of age. 100mg, 200mg, 600mg admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 23091 Croatia OTC Secretolytic treatment of acute and chronic bronchopulmonary diseases accompanied by disorder production and expulsion of mucus in adults, adolescents and children older than 2 years. Treatment of acute and chronic diseases of the respiratory system with 100mg, 200mg, 600mg tablet, 200mg/5ggranules Pharma forms: Effervescent tablets,granules Distribution in pharmacies Advertising togeneral public allowed Administration starts from children older than 2 years of age admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 23092 Czech Republic OTC For therapy in acute and chronic respiratory diseases pathways associated with the formation of viscous mucus and difficult expectoration (acute and chronic bronchitis, bronchiectasis, asthmatic bronchitis, bronchial asthma, bronchiolitis, cystic fibrosis 20mg/ml, 100mg, 200mg, 600mg, Mucolytic treatment of acute respiratory diseases. Maximum strength 600mg or 20mg/ml, maximum single dose 600mg or 200mg, maximum daily dose 600mg. admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 23093 Denmark OTC Secretolytic treatment in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport in adults (600mg), in adults, adolescents and children from 6 years of age (200mg). 200mg, 600mg effervescent tablets. admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 23094 Estonia OTC Secretolytic therapy in acute and chronic bronchopulmonary diseases accompanied by impaired formation and transport of mucus To liquefy the mucus and ease expectoration in cold-induced bronchitis 100mg, 200mg, 600mg, 20mg/ml Pharma form: Powder for solution, effervescent tablet Age: children from 2 years, adolescents and adults. Medicinal product with marketing authorization admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 1987 23095 Finland OTC Respiratory diseases, especially during acute bronchitis. 200mg, 600mg Limit per pack 6g (200mg per unit). OTC for adults and adolescents over 12 years of age. admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Acetylcysteine Oral R R05 23096 France OTC Treatment of bronchial secretion disorders, particularly during acute bronchial conditions: acute bronchitis and acute episode of chronic bronchopneumopathy.600mg: This medication is indicated in adults for the treatment of bronchial conditions in which 200mg, 600mg, 2% 200mg: adults and children aged 2 and over. 600mg: Other presentations and concentrations of acetylcysteine are better suited for children and adolescents. Not indicated in children under 2 years of age. 2%: children over 2 years of age. admiAV 03/07/2024 05:37 PM admiAV 19/07/2024 08:50 AM
Acetylcysteine Oral R R05 1994 23097 Germany OTC To liquefy mucus and make it easier to cough up in cold-related bronchitis. 100mg, 200mg, 600mg, 20mg/ml Adults and children over 6 years of age (common cold). admiAV 03/07/2024 05:37 PM admiAV 03/07/2024 05:37 PM
Active ingredient Administration route ATC Level 1 ATC Level 2 Country Status Indication Pharmaceutical form Strength Dosage/posology Population